INPLASY2025100062

Effectiveness and Safety of Adalimumab versus Infliximab in Refractory Uveitis: A Systematic Review and Meta-Analysis with Moderator Evaluation

Keywords: refractory uveitis, adalimumab, infliximab.

Review Status: ongoing